Johns Hopkins researchers are spearheading efforts to raise awareness and learn more about a sexually transmitted disease few people know about but scientists believe makes people infertile. Many people infected with mycoplasma genitalium , or Mgen for short, do not show symptoms and might not know they are carrying the disease. There's no approved test for it, which makes it difficult to track, but doctors believe it's more common than gonorrhea, infecting about 1 to 3 percent of the population.
All news from Venereology
Study confirms biological mechanism responsible for latent HIV reservoirs; suggests strategies for a functional HIV cure. A majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originated from cellular proliferation, not viral replication, according to new research published in Nature Communications.
An underused strategy for surge In STDs: Treat the patients’ partners without a doctor visit If patients return to Dr. Crystal Bowe soon after taking medication for a sexually transmitted infection, she usually knows the reason: Their partners have re-infected them. “While you tell people not to have sex until both folks are treated, they just don’t wait,” she said. “So they are passing the infection back and forth.”
HIV, the virus that causes AIDS, has been studied extensively ever since the AIDS epidemic was officially recognized by health professionals in the early 1980s. During that time, research has led to the development of effective antiretroviral drugs that in many cases prevent an HIV-infected person from developing AIDS.
If patients return to Dr. Crystal Bowe soon after taking medication for a sexually transmitted infection, she usually knows the reason: Their partners have re-infected them. "While you tell people not to have sex until both folks are treated, they just don't wait," she said. "So they are passing the infection back and forth."
In a study of proteins historic in its scope, researchers at Oregon State University have pushed closer both to a vaccine for gonorrhea and toward understanding why the bacteria that cause the disease are so good at fending off antimicrobial drugs.
The management of human immunodeficiency virus 1 (HIV), an autoimmune disorder that cripples the immune system by attacking healthy cells, remains a major global health challenge in developing countries that lack infrastructure and trained medical professionals.
Investigators from Brigham and Women's Hospital have designed a portable and affordable mobile diagnostic tool, utilizing a cellphone and nanotechnology, with the ability to detect HIV viruses and monitor its management in resource-limited regions. The novel platform is described in a paper published recently in Nature Communications.
A study published in The Lancet HIV shows that HIV-2 is more pathogenic than previously demonstrated. The new findings indicate that treatment should be applied to all patients with HIV, not only to those with HIV-1.
An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in Phase 2 multicenter clinical trial, according to findings published in the New England Journal of Medicine. The National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health, sponsored the clinical study.
Immunotherapy has been a major breakthrough in oncology, with registered drugs now approved for use in an increasing number of tumour types – but little is known about its safety for HIV-positive cancer patients. A study (1) to be presented at the ESMO 2018 Congress in Munich has now provided data to suggest that treatment with PD-1/PD-L-1 immune checkpoint inhibitors, which target the very system affected by the HIV virus, is feasible in this patient population for whom cancer is currently one of the principal cause of mortality.
Teenagers with HIV and their families can improve care about health care goals when advance care planning is discussed with a doctor early in the course of treatment, according to research published in Pediatrics. This agreement, according to the researchers, can reduce HIV symptoms and suffering for the patient.
A new study reveals that HIV-infected adults in the United States are at a higher risk of developing cancers caused by the human papillomavirus (HPV) than Hispanics from the general population. Published early online in CANCER, the findings highlight the need for continued efforts to develop and implement appropriate HPV-vaccination and cancer screening programs for individuals with HIV, and for additional research that explains the causes of racial / ethnic disparities in HPV-related cancer occurrences.